These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30520388)

  • 1. miR-342-5p as a Potential Regulator of HER2 Breast Cancer Cell Growth.
    Lindholm EM; Leivonen SK; Undlien E; Nebdal D; Git A; Caldas C; Børresen-Dale AL; Kleivi K
    Microrna; 2019; 8(2):155-165. PubMed ID: 30520388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.
    Leivonen SK; Sahlberg KK; Mäkelä R; Due EU; Kallioniemi O; Børresen-Dale AL; Perälä M
    Mol Oncol; 2014 Feb; 8(1):93-104. PubMed ID: 24148764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional SNP in stem of mir-146a affects Her2 status and breast cancer survival.
    Meshkat M; Tanha HM; Naeini MM; Ghaedi K; Sanati MH; Meshkat M; Bagheri F
    Cancer Biomark; 2016 Jul; 17(2):213-22. PubMed ID: 27434289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-4728-3p could act as a marker of HER2 status.
    Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
    Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.
    Lund RR; Leth-Larsen R; Caterino TD; Terp MG; Nissen J; Lænkholm AV; Jensen ON; Ditzel HJ
    Mol Cell Proteomics; 2015 Nov; 14(11):2988-99. PubMed ID: 26351264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
    Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
    Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K/AKT pathway.
    Liu Y; Yang H
    Cancer Biol Ther; 2023 Dec; 24(1):2224512. PubMed ID: 37394766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer.
    Tan X; Li Z; Ren S; Rezaei K; Pan Q; Goldstein AT; Macri CJ; Cao D; Brem RF; Fu SW
    Breast Cancer Res; 2019 Aug; 21(1):89. PubMed ID: 31391072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2-intronic miR-4728-5p facilitates HER2 expression and accelerates cell proliferation and migration by targeting EBP1 in breast cancer.
    Zhou Y; Yuan Y; Li L; Wang X; Quan Y; Liu C; Yu M; Hu X; Meng X; Zhou Z; Zhang CY; Chen X; Liu M; Wang C
    PLoS One; 2021; 16(2):e0245832. PubMed ID: 33529238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b.
    Sun Y; Liu X; Zhang Q; Mao X; Feng L; Su P; Chen H; Guo Y; Jin F
    Tumour Biol; 2016 Apr; 37(4):4963-72. PubMed ID: 26531722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PVT1-derived miR-1207-5p promotes breast cancer cell growth by targeting STAT6.
    Yan C; Chen Y; Kong W; Fu L; Liu Y; Yao Q; Yuan Y
    Cancer Sci; 2017 May; 108(5):868-876. PubMed ID: 28235236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2.
    Mansoori B; Kiani S; Mezajin AA; Zandi P; Banaie H; Rostamzadeh D; Cho WC; Duijf PHG; Mansoori B; Baradaran B
    Clin Breast Cancer; 2023 Oct; 23(7):e480-e490.e3. PubMed ID: 37596147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
    Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
    Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A.
    Yang K; Li D; Jia W; Song Y; Sun N; Wang J; Li H; Yin C
    Thorac Cancer; 2022 Jul; 13(13):1916-1924. PubMed ID: 35608059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-199b-5p targets HER2 in breast cancer cells.
    Fang C; Zhao Y; Guo B
    J Cell Biochem; 2013 Jul; 114(7):1457-63. PubMed ID: 23296799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
    Wu X; Kong C; Wu Y
    Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the Dysregulation of miR-23b-3p, miR-195-5p, miR-656-5p, and miR-340-5p in Trastuzumab Resistance of HER2-Positive Breast Cancer Cells and System Biology Approach to Predict Their Targets Involved in Resistance.
    Rezaei Z; Sebzari A; Kordi-Tamandani DM; Dastjerdi K
    DNA Cell Biol; 2019 Feb; 38(2):184-192. PubMed ID: 30702337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic application of
    Cava C; Novello C; Martelli C; Lodico A; Ottobrini L; Piccotti F; Truffi M; Corsi F; Bertoli G; Castiglioni I
    Theranostics; 2020; 10(1):50-61. PubMed ID: 31903105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis.
    Laurin M; Huber J; Pelletier A; Houalla T; Park M; Fukui Y; Haibe-Kains B; Muller WJ; Côté JF
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7434-9. PubMed ID: 23592719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of miR-362-5p and miR-454-3p expression elicits diverse responses in breast cancer cell lines.
    Aarthy R; Rao AKDM; Patel K; Sridevi V; Rajkumar T; Gowda H; Mani S
    Mol Biol Rep; 2022 Jan; 49(1):821-826. PubMed ID: 34727290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.